Literature DB >> 31053452

[Mental health in Spain and differences by sex, and by autonomous communities].

Jesús Henares Montiel1, Isabel Ruiz-Pérez2, Luis Sordo3.   

Abstract

OBJECTIVE: To describe the evolution of psychological distress in the adult Spanish population in 2006, 2011 and 2017. To study the mental health status of the population in 2017 analyzing the prevalence of psychological distress, prescription of psychiatric drugs, diagnosis and self-perceived health, in Spain and in the autonomous regions, and differentiating between men and women.
METHOD: Cross-sectional study, using data from the 2006, 2011 and 2017 National Health Surveys in Spain. VARIABLES: psychological distress (GHQ-12), self-perceived health, mental disorder diagnosis, prescription of psychiatric drugs, sex and autonomous community. The frequencies, percentages and confidence intervals at 95% were calculated. The statistical significance level for the chi-square test was p <0.05.
RESULTS: The prevalence of psychological distress in Spain was 22.2% in 2006, 22.1% in 2011 and 19.1% in 2017. With the exception of Cantabria in 2011, in all cases the prevalence of psychological distress was higher in women than men. In 2017, most of the autonomous communities showed prevalence of diagnosis and poor self-perceived health near the Spanish average (15.4% and 33.6%, respectively). The Spanish average of tranquilizer prescription was 9.2%. The highest prevalence was found in Galicia while the lowest was found in Cantabria (overall population and men) and Ceuta and Melilla (women). The Spanish average of antidepressant prescription was 3.6%. The highest prevalence was found in Asturias (overall population and women) and in Galicia (men), while the lowest was found in Ceuta and Melilla.
CONCLUSIONS: Psychological distress is a prevalent phenomenon although its prevalence in Spain has decreased slightly. There are big differences in the prescription of psychiatric drugs between each autonomous community. Women showed poorer outcomes on each mental health indicator analyzed.
Copyright © 2019 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Autonomous community; Comunidades autónomas; Desigualdades de género; Encuesta Nacional de Salud; Gender inequalities; Mental health; National Health Survey; Psicofármacos; Psychiatric drugs; Salud mental

Year:  2019        PMID: 31053452     DOI: 10.1016/j.gaceta.2019.03.002

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  12 in total

1.  Impact of Social Determinants of Health on Women's Satisfaction with Their Sexual Life and Its Relationship with the Use of Psychotropic Drugs: A Cross-Sectional Study.

Authors:  Regina Ruiz de Viñaspre-Hernández; Iván Santolalla-Arnedo; Rosana Garrido-Santamaría; Michał Czapla; Clara Isabel Tejada-Garrido; Juan Luis Sánchez-González; Esther Sapiña-Beltrán; Verónica Iriarte-Moreda; María Estela Colado-Tello; Vicente Gea-Caballero; Raúl Juárez-Vela
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.964

2.  Related Health Factors of Psychological Distress During the COVID-19 Pandemic in Spain.

Authors:  Juan Gómez-Salgado; Montserrat Andrés-Villas; Sara Domínguez-Salas; Diego Díaz-Milanés; Carlos Ruiz-Frutos
Journal:  Int J Environ Res Public Health       Date:  2020-06-02       Impact factor: 3.390

3.  Self-rated health inequalities in the intersection of gender, social class and regional development in Spain: exploring contributions of material and psychosocial factors.

Authors:  Núria Pedrós Barnils; Eva Eurenius; Per E Gustafsson
Journal:  Int J Equity Health       Date:  2020-06-05

4.  Mental Health Patients' Expectations about the Non-Medical Care They Receive in Primary Care: A Cross-Sectional Descriptive Study.

Authors:  Valle Coronado-Vázquez; Dolores Museros-Sos; Bárbara Oliván-Blázquez; Rosa Magallón-Botaya; Juan Gómez-Salgado; María Antonia Sánchez-Calavera; Bárbara Masluk; María Josefa Gil-de-Gómez; Eva Rodríguez-Eguizábal
Journal:  Healthcare (Basel)       Date:  2020-07-27

5.  Depression and Exercise in Older Adults: Exercise Looks after You Program, User Profile.

Authors:  Carmen Galán-Arroyo; Damián Pereira-Payo; Miguel Ángel Hernández-Mocholí; Eugenio Merellano-Navarro; Jorge Pérez-Gómez; Jorge Rojo-Ramos; Jose Carmelo Adsuar
Journal:  Healthcare (Basel)       Date:  2022-01-18

6.  Prevalence and Associated Factors of Common Mental Disorders in Women: A Systematic Review.

Authors:  Héllyda de Souza Bezerra; Roberta M Alves; Aryelly Dayanne D Nunes; Isabelle R Barbosa
Journal:  Public Health Rev       Date:  2021-08-23

7.  Mental Health among Spanish Adults with Diabetes: Findings from a Population-Based Case-Controlled Study.

Authors:  Marta Lopez-Herranz; Rodrigo Jiménez-García; Zichen Ji; Javier de Miguel-Diez; David Carabantes-Alarcon; Clara Maestre-Miquel; José J Zamorano-León; Ana López-de-Andrés
Journal:  Int J Environ Res Public Health       Date:  2021-06-04       Impact factor: 3.390

8.  Gender Differences in the Prevalence of Mental Health, Psychological Distress and Psychotropic Medication Consumption in Spain: A Nationwide Population-Based Study.

Authors:  Clara Maestre-Miquel; Ana López-de-Andrés; Zichen Ji; Javier de Miguel-Diez; Arturo Brocate; Sara Sanz-Rojo; Antonio López-Farre; David Carabantes-Alarcon; Rodrigo Jiménez-García; José J Zamorano-León
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390

9.  Addressing Dual Disorders in a Medium-Term Admission Unit.

Authors:  Francisco Arnau; Ana Benito; Mariano Villar; María Elena Ortega; Lucía López-Peláez; Gonzalo Haro
Journal:  Brain Sci       Date:  2021-12-26

10.  Increased Odds for Depression and Antidepressant Use in the Inactive Spanish Population.

Authors:  Carmen Galán-Arroyo; Damián Pereira-Payo; Jorge Rojo-Ramos; Miguel A Hernández-Mocholí; Eugenio Merellano-Navarro; Jorge Pérez-Gómez; Ángel Denche-Zamorano; Jose Carmelo Adsuar
Journal:  Int J Environ Res Public Health       Date:  2022-02-28       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.